Showing 831-840 of 1576 results for "".
Advances in Ocular Drug Delivery
https://modernod.com/topics/nutritionpharmaceuticals/advances-in-ocular-drug-delivery/38624/Innovative technologies mitigate side effects, reduce product waste, and enhance visual outcomes.What’s New and What’s Coming in OSD Treatment
https://modernod.com/topics/ocular-surface/whats-new-and-whats-coming-in-osd-treatment/38578/An overview of recent FDA approvals and potential new therapies.The Emergence of Longevity Biotechnology in Eye Care
https://modernod.com/topics/technology/the-emergence-of-longevity-biotechnology-in-eye-care/38292/Several strategies are being explored to halt or reverse the effects of aging.- Orasis Announces Appointments of Richard L. Lindstrom, Eric D. Donnenfeld, and John Berdahl to its Scientific Advisory Boardhttps://modernod.com/news/orasis-announces-appointments-of-richard-l-lindstrom-eric-d-donnenfeld-and-john-berdahl-to-its-scientific-advisory-board/2479644/Orasis Pharmaceuticals announced the appointment of Richard L. Lindstrom, MD, Eric D. Donnenfeld, MD, and John Berdahl, MD, to its scientific advisory board. Dr. Lindstrom, Dr. Donnenfeld, and Dr. Berdahl have joined existing scientific advisory board members Sheri Rowen, MD, and Michael Korenfel
- Neurotech Pharmaceuticals Appoints John Pollack, MD, as Chief Medical Officerhttps://modernod.com/news/neurotech-pharmaceuticals-appoints-john-pollack-md-as-chief-medical-officer/2478549/Neurotech Pharmaceuticals announced that John Pollack, MD, has been appointed to the position of Chief Medical Officer (CMO). Dr. Pollack’s responsibilities will include the execution of clinical studies, patient safety, and the management of Medical Affairs; supporting the required regulatory su
- Visus Therapeutics Appoints Eric D. Donnenfeld, MD, to Board of Directorshttps://modernod.com/news/visus-therapeutics-appoints-eric-d-donnenfeld-md-to-board-of-directors/2481347/Visus Therapeutics announced the appointment of Eric D. Donnenfeld, MD, to the company’s Board of Directors. Dr. Donnenfeld brings more than 30 years of clinical experience as an internationally recognized expert in refractive, cornea, and cataract surgery. “I am thrill
- Stephen D. McLeod, MD, Selected as Next CEO of American Academy of Ophthalmologyhttps://modernod.com/news/stephen-d-mcleod-md-selected-as-next-ceo-of-american-academy-of-ophthalmology/2480346/The American Academy of Ophthalmology board of trustees announced the unanimous selection of Stephen D. McLeod, MD, 57, as the Academy’s next chief executive officer (CEO). Dr. McLeod currently is the Theresa M. and Wayne M. Caygill, M.D. Distinguished Professor and Chair, Department of Oph
- Optovue Announces Retirement of Industry Veteran John Hawleyhttps://modernod.com/news/optovue-announces-retirement-of-industry-veteran-john-hawley/2480137/Optovue announced the retirement of renowned industry veteran John Hawley, the company’s senior vice president of global sales. Mr. Hawley will retire on July 1, 2018, and remain with Optovue in an advisory role. “For the past 10 years, I have worked side-by-side with John as we built Opto
- Quantel Medical Launches POCKET III Handheld Pachymeterhttps://modernod.com/news/quantel-medical-launches-pocket-iii-handheld-pachymeter/2482298/Quantel Medical, a division of Lumibird Medical, announced the launch of the POCKET III handheld pachymeter. With its compact design, Quantel says the POCKET III is the lightest connected handheld pachymeter on the market weighing just 60 grams. It offers a precise a
- Alcon Names Daniel M. Miller, MD, PhD, Senior Scientific Advisor to Alcon's R&D team PDFhttps://modernod.com/news/alcon-names-daniel-m-miller-md-phd-senior-scientific-advisor-to-alcons-rd-team-pdf/2481584/Alcon announced that the highly esteemed ophthalmologist, Daniel M. Miller, MD, PhD, will join Alcon as a member of the Research and Development (R&D) team. Dr. Miller is a fellowship-trained medical and surgical retina specialist. He will serve as a Senior Scientific Advisor to Alc